Statistics for Favorable response of metastatic merkel cell carcinoma to targeted 177Lu-DOTATATE therapy: Will PRRT evolve to become an important approach in receptor-positive cases?
Total visits
| views | |
|---|---|
| Favorable response of metastatic merkel cell carcinoma to targeted 177Lu-DOTATATE therapy: Will PRRT evolve to become an important approach in receptor-positive cases? | 0 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |